Sanofi-Aventis has a strong focus on difficult-to-treat diseases and immunization. Their R&D pipeline includes 78 clinical-stage projects, 23 of which are in phase 3 or have been submitted to regulatory authorities for approval.
Sanofi-Aventis Korea
Category:
Global
Main Business Area
Difficult-to-treat diseases and immunization
| Contact Details | 235 Banpo-daero, Seocho-gu, Seoul (Zip code 06578) |
|---|
